Results 181 to 190 of about 30,881 (226)
Comparison of outcomes with elranatamab and real world treatments in the UK for triple class exposed relapsed and refractory multiple myeloma. [PDF]
Tsang C +9 more
europepmc +1 more source
[Comorbidities in multiple sclerosis and their influence on the choice of treatment]. [PDF]
Barboza A +8 more
europepmc +1 more source
[Teaching assistants in Argentina have greater intentions to migrate abroad as physicians than other medical students] [PDF]
Pereyra V +4 more
europepmc +1 more source

